Tectonic Therapeutic, Inc. TECX
Set alert
19.03 USD +0.05 +0.27%
As of Nov 3, 12:47 PM ET
18.76 Day range 19.74
15.52 52-week range 39.53
- YTD
- -8.77%
- 1 year
- +8.69%
- Open
- 19.13
- Prev close
- 18.98
- Mkt cap
- 372.12M
- Vol
- 54.82K
- Avg vol
- 220.29K
- EPS
- -4.57
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.76
- High
- 19.74
- Forward P/E
- -10.16
- Beta
- 0.00
- Short ratio
- 3.54
- Inst. own
- 46.91%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 43.40
- 200-d avg
- 24.05
- 1y target
- 74.67
YTD chart
Signals (55)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 2026 | 1 day ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 13, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
Newest 20 of 55.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 74.67 +292.3% upside
Now 19.03
- Target (low)
- 69.00
- Target (mean)
- 74.67
- Target (high)
- 79.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 5
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Raymond James | Initiated | — | Outperform |
| Nov 12, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 11, 2024 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 22, 2024 | Wells Fargo | Initiated | — | Overweight |
| Jul 24, 2024 | Leerink Partners | Initiated | — | Outperform |
| Jun 26, 2024 | Piper Sandler | Initiated | — | Overweight |
| Jun 24, 2024 | TD Cowen | Initiated | — | Buy |